Press/Media
- 200 - 225 out of 400 results
Search results
-
Edible 'security tag' to protect drugs from counterfeit
20/1/16 → 20/1/19
5 items of Media coverage
Press/Media: Press / Media
-
Activity and Safety Recognition using Smart Work Shoes for Construction Worksite.
20/2/1
1 item of Media coverage
Press/Media: Press / Media
-
Korean Rhinologic Society
Chang-Hoon Kim, Hee Seung Lee, Jong-Seok Lee, Jongeun Lee & YoungWan Kim
20/2/5
1 item of Media coverage
Press/Media: Press / Media
-
U.S. Patent and Trademark Office Publishes University Industry Foundation, Yonsei University Wonju Campus and Research & Business Foundation Sungkyunkwan University's Patent Application for Pickering Emulsion Composition Using Polyimide Particles and Prep
20/3/13
1 item of Media coverage
Press/Media: Press / Media
-
South Korea says no unusual signs of Kim Jong Un’s health detected
20/4/21
1 item of Media coverage
Press/Media: Press / Media
-
Kim Jong Un sister Kim Yo Jong: The next ruler of North Korea?
20/4/30
1 item of Media coverage
Press/Media: Press / Media
-
Kim Jong Un's sister Kim Yo Jong: The next ruler of North Korea?
20/4/30
1 item of Media coverage
Press/Media: Press / Media
-
North Korea: Kim Jong Un's sister Kim Yo Jong: The next ruler of North Korea?
20/5/1
2 items of Media coverage
Press/Media: Press / Media
-
Hyundai Motor and Industry-Academic Cooperation Foundation Yonsei University Granted Patent for Thermoelectric Nanocomposite and Process of Producing the Same
20/5/5
1 item of Media coverage
Press/Media: Press / Media
-
Celltrion Healthcare: New Phase II data indicate regimen of Truxima (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in relapsed/refractory aggressive B-cell lymphoma
20/6/14
1 item of Media coverage
Press/Media: Press / Media
-
New Phase II data indicate regimen of Truxima (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in relapsed/refractory aggressive B-cell lymphoma
20/6/15
1 item of Media coverage
Press/Media: Press / Media
-
New Phase II data indicate regimen of Truxima®...
20/6/14 → 20/6/15
3 items of Media coverage
Press/Media: Press / Media
-
New Phase II data indicate regimen of Truxima® (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in relapsed/refractory aggressive B-cell lymphoma
20/6/14 → 20/6/17
9 items of Media coverage
Press/Media: Press / Media
-
-
5 Prettiest Universities in Seoul That Will Make You Want to Study There
Jung-Hyun Kim, minjung Kim & YoungWan Kim
20/6/30
1 item of Media coverage
Press/Media: Press / Media
-
Univ Industry Foundation Yonsei Univ Wonju Campus and Research & Business Found Sungkyunkwan Univ Apply for Patent on Pickering Emulsion Composition Using Polyimide Particles and Preparation Method Thereof
20/7/5
1 item of Media coverage
Press/Media: Press / Media
-
Hyundai Motor, Kia Motors and Industry-Academic Cooperation Foundation Yonsei University Awarded Patent for Thermoelectric Material and Method for Preparing the Same
20/7/14
1 item of Media coverage
Press/Media: Press / Media
-
Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites
20/9/17
1 item of Media coverage
Press/Media: Press / Media
-
Australia Patent: Yonsei University Industry-Academic Cooperation Foundation, Korea Research Institute of Chemical Technology File Application for 'Compounds for inhibiting TNIK and medical uses thereof'
20/9/18
1 item of Media coverage
Press/Media: Press / Media
-
Clinical Trial: Smartwatch ABPM vs. Conventional ABPM
20/9/19
2 items of Media coverage
Press/Media: Press / Media
-
Univ Industry Foundation Yonsei Univ Wonju Campus Applies for Patent on - a Method for Simultaneously Detecting and Identifying Helicobacter Pylori and an Antibiotics-Resistance Gene Thereof and a Use Therefor Based Pcr-Reverse Blot Hybridization Assay
20/10/12
1 item of Media coverage
Press/Media: Press / Media
-
IRIS-Synergy Cohort in the IRIS-DES Registry
20/10/24
1 item of Media coverage
Press/Media: Press / Media
-
Deep Learning-based Fully Automated Detection and Quantification of Acute Infarcts
20/10/25
1 item of Media coverage
Press/Media: Press / Media
-
Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment
20/10/27
1 item of Media coverage
Press/Media: Press / Media